Lung Cancers Cost Asian Economies Trillions in Staggering Welfare Losses

Tracheal, bronchial, and lung cancers cost Asian economies a staggering 3.28 trillion dollars in welfare losses in 2023, consuming over 4 percent of the region’s total economic output. That heavy financial toll, which extends far beyond direct medical expenses, reflects an uneven health crisis driven by aging populations, tobacco use, and environmental pollution across 46 countries.

A Massive Financial Strain Across Asian Economies

The total value of lost welfare attributed to tracheal, bronchial, and lung cancers in Asia reached 3.28 trillion dollars in 2023, according to a comprehensive study published in Frontiers in Public Health. This economic loss represents roughly 4.18 percent of the entire continent’s gross domestic product. The researchers used a framework that monetizes disability-adjusted life years, measuring both market losses like reduced labor income and non-market impacts such as diminished health and leisure.

East Asia bore the largest share of this economic burden, accounting for 61.3 percent of the continental total, followed by high-income Asia-Pacific countries at 14.6 percent. China recorded the highest absolute welfare loss in the region at 2.01 trillion dollars, driven by its massive population size and high incidence rates. Japan and Türkiye followed with losses of 354.1 billion dollars and 174.0 billion dollars, respectively.

When looking at the ratio of welfare loss to gross domestic product, the picture shifted. Smaller economies such as Cyprus, Georgia, and Armenia displayed relative economic burdens that rivaled or exceeded those of wealthier nations because limited national economic outputs magnified the impact of the disease.

Who Bears the Heaviest Toll of Lung Cancer

The economic burden of tracheal, bronchial, and lung cancers across Asia was heavily skewed toward older adults and male populations. Financial losses remained near zero for individuals under 15 years old, began climbing in the teen years, and peaked sharply among adults aged 70 to 74 years.

Male populations experienced significantly higher welfare losses than female populations across nearly all age groups. Researchers attributed this gender gap to higher historical and current smoking rates among men in many Asian countries, alongside occupational exposures to known carcinogens like asbestos and radon in heavy industries.

However, the analysis revealed a notable exception among the oldest old. In the demographic group aged 95 years and older, female welfare losses surpassed those of male populations, highlighting changing longevity patterns and distinct vulnerability factors in advanced age.

Rising Inequality and Future Projections Through 2050

Health inequality analysis demonstrated a widening gap between regions with different socioeconomic development levels. The slope index of inequality, a measure of absolute disparity, increased by 157.3 percent from 1990 to 2023. This trend shows that populations in lower socioeconomic settings face a growing disadvantage in disease management and financial protection.

Looking ahead, mathematical models project that the absolute economic burden will climb to approximately 12.13 trillion dollars by the year 2050, representing a 270 percent increase from 2023 levels. The share of regional gross domestic product devoted to these losses is projected to reach 5.76 percent by mid-century as populations age further.

The study authors noted several limitations in their work, including reliance on secondary modeling sources and database estimates where primary health reporting in low-income countries remains sparse. Furthermore, the economic valuations were based primarily on high-income benchmarks, suggesting that actual local hardship could be even higher than reported figures indicate.

The research was published in Frontiers in public health on October 27, 2026.